|
|
![]() |
|
THE JOURNAL OF RHEUMATOLOGY Manuscripts and all other editorial communications addressed to the Editor of The Journal of Rheumatology should be submitted via our online submission system, available at the Manuscript Central website. To submit a new manuscript start your web browser and visit http://mc.manuscriptcentral.com/jrheum. Check online records for an existing account. If you are submitting for the first time, create a new account. Follow all online instructions. At the end of successful submission, a confirmation screen with manuscript number will appear and you will receive an E-mail acknowledging that the manuscript has been received. If this does not happen, please check your submission and/or contact our technical support staff at manuscripts@jrheum.com . Manuscript, figures, and tables should be submitted as separate files. You do not need to mail any copies. Articles, editorials, reviews, hypotheses, case reports of exceptional interest, images in rheumatology, and letters will be accepted for publication following successful review and on condition that they are submitted solely to this journal. Case reports should be submitted as letters to the Editor. Subject matter may relate to the broad field of rheumatology, rehabilitation medicine, immunology, infectious diseases or orthopedic subjects pertaining to the rheumatic diseases. Manuscripts containing original material are accepted for consideration with the understanding that neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted for publication elsewhere before appearing in The Journal. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. Conflict of Interest: The Journal asks authors of research articles to disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader. Because the essence of editorials and reviews is selection and interpretation of the literature, The Journal expects that authors of such articles will disclose any financial interest in a company (or its competitor) that makes a product discussed in the article. Potential authors who have questions about these issues should contact the Editor. The Journal of Rheumatology discourages submission of more than one article dealing with related aspects of the same study. If authors are aware of any published paper or other manuscript in preparation or submitted elsewhere or to The Journal related to the manuscript under consideration (e.g., another manuscript resulting from the same study), a copy of the related paper should be uploaded as a supplementary file with the paper submitted for publication. Articles are considered only for exclusive publication in The Journal with the understanding that they have not been published elsewhere (in part or in full, in other words or in the same words in letter or article form, or otherwise), are not at the time of submission under consideration by another journal or other publication, and will not be submitted elsewhere unless rejected by The Journal of Rheumatology. If an author violates this requirement or engages in other similar misconduct, the Editor may, in addition to rejecting the manuscript, impose a moratorium on the acceptance of new manuscripts from the author and if the misconduct is deemed sufficiently serious, may refer the matter to the author's academic institution or hospital and/or the appropriate disciplinary body. For articles reporting clinical trials, registration in an appropriate public registry before the start of patient enrollment is strongly encouraged. Authors of articles reporting registered trials should include the trial registration number in the Abstract and in the Materials and Methods sections of their manuscript. The registration number will be published in articles accepted for publication. Preparation of Manuscripts Manuscripts should be concise and typed double-spaced with liberal margins. Journal titles cited in the references must conform to the abbreviations used in Index Medicus and follow the style shown below. Manuscripts should be submitted online accompanied by a covering letter indicating that the final manuscript has been seen and approved by all the authors and that they have given necessary attention to ensure the integrity of the work. The covering letter should note the type of manuscript submitted (full-length article, brief communication, case report [in letter format], images in rheumatology, or letter to the editor). The manuscript, accompanying tables, and figures should be prepared for online submission and review using conventional software. Number each page, including tables and figure legends, in sequence. Organize the manuscript to include: Title Page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgment, References, Tables, Figures, and Figure Legends. For full-length articles and brief communications submit a structured abstract of no more than 250 words and 100 words, respectively. Indicate the main sections of the manuscript by side headings. Use the Arabic numbering system throughout the manuscript except at the beginning of sentences. Check manuscripts carefully before submission. To aid in the review process, include the statistical worksheet (not for publication), if applicable. Because of increasing publication costs, present the message as concisely as possible. For example, the Discussion should not exceed half the length of the whole article (preferably a third). Authors are encouraged to suggest the names of 3 or 4 persons who might be considered suitable reviewers of their work. Brief communications are short investigative papers and reports organized in the same manner as full-length manuscripts, but which contain 1000 words or less, with no more than 3 figures or tables, and up to 15 references. Case Reports are abbreviated case descriptions of exceptional clinical findings and clinical course, and should be submitted in the format of letters to the Editor (see below). Editorials and review articles are usually solicited by the editors, but unsolicited material is also considered. Before submitting an editorial or a review, send a brief summary to the editor. Manuscripts on novel topics of interest will be recommended for submission and peer-review. Editorials and review articles on rheumatologic aspects of clinical practice, clinical therapeutics, current concepts, drug therapy, and mechanisms of disease are considered. Editorials are up to 1500 words, with up to 2 figures/ tables (total) and 20 references. Reviews are up to 3000 words, with a maximum of 4 figures/tables (total) and up to 50 references. These articles do not include an abstract. Images in Rheumatology are abbreviated case descriptions of abstract length (about 250 words and 3 to 5 references) that feature exceptional visual illustrations. Correspondence in the form of a Letter to the Editor should not exceed 800 words, with a maximum of 10 references and no more than 2 figures (submitted per above guidelines) or tables; and no subdivision for an abstract, methods, or results. Letters should have no more than 4 authors. Supplements. The Journal welcomes the opportunity to publish proceedings of significant symposia providing the material represents original work not previously published. Symposium organizers are urged to contact the Editor well in advance of the symposium date with a draft program. Faculty, subject matter, and editorial content are all subject to the approval of the editorial committee. Papers submitted to be published in the proceedings must conform to the style for supplements, which is available on request, before they will be considered for publication. Details of Format and Organization Title Page. Title page should be prepared in the following order:
Acknowledgment, if applicable, should be added at the end of the discussion of the paper and before the references. It should not acknowledge grant or industrial support for fellowship awards, all of which should appear on the title page. Prepare each table on a separate page, double-spaced. Number tables consecutively and supply a brief legend for each. References cited only in tables should be numbered in the sequence established by identification in the text. General requirements for preparation of artwork. Figures should be professionally drawn and photographed, with the critical area of radiographs or photomicrographs indicated. Figures and figure labeling should be prepared for sizing to a single or a double column of text without loss of information. Figure labeling should be sized in proportion to the rest of the figure. For publication, figures are printed in black and white unless color is necessary for proper interpretation. Authors must bear all the costs of color printing. The publications office at your institution may be able to assist with preparation of artwork intended for publication. Line drawings (charts, diagrams, etc.). When supplying diagrams or charts for the printed journal, authors should avoid use of solid and shaded background and fill effects; if necessary for interpretation, coarse stippling or hatching is recommended. If possible supply figures in a form that retains editing features of the source program (e.g., a chart or graph created in MS Excel). To ascertain whether charts and diagrams can be processed to display adequately on publication, print them out in black and white on a good quality laser printer: they should appear as high quality representations, with prominent, clear labeling and should allow for a slight loss of detail. Half-tone figures (photographs, etc.). For online peer review, separate low-resolution figures are preferred. For acceptable formats see our online submission instructions. To meet requirements for both online review and print publication, authors should initially create half-tone figures of sufficient quality and resolution (300 dots per inch) to allow some loss of contrast and detail in printing and save figures in a standard graphic file format such as jpeg or tiff; authors should then save a second, low-resolution version for the submission/review process. The legend to each figure should be inserted in your manuscript following the references section, as well as with each separately uploaded figure. The final figures for publication should be supplied by uploading them as separate files to our online submission system on Scholar One. A second option for supplying final half-tone figures is to print them on high quality, glossy paper and mail them to our publication office. Number references consecutively in the order in which they are mentioned in the text. Identify references in text, tables, and legends by Arabic numerals (in parentheses). References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration. Journal. Standard Journal Article (List all authors, but when 7 or more, list 6 and add "et al"): Soter NA, Wasserman SI, Austen KF. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med 1976;294:687-90. Contributors are provided with page proofs and are asked to proofread them for typesetting errors. Important changes in data are allowed, but authors will be charged for excessive alterations in proof. Proofs must be returned within 48 hours. Reprints may be purchased by contributors when ordered before publication. An order form showing the costs of reprints will accompany the proofs. Announcements. These should be sent to the Editor and must be received 3 months before publication.Page charges. A $60 per page charge will be assessed for publication in The Journal of Rheumatology. Instructions for payment will be sent to authors along with the page proofs. There is no charge for solicited articles or for correspondence commenting on published articles. In cases of extreme financial difficulty, consideration will be given to waiving page charges. Inquiries should be addressed to the managing editor. Self-Archiving Policy for Publicly Funded Research. Authors of original research articles whose funding agency requires public access to the funded research may deposit their accepted manuscript in PDF format to institutional and/or centrally organized repositories (including PubMed Central), but must stipulate that public access to the manuscript be delayed until 12 months after first online publication in The Journal of Rheumatology. When depositing an accepted manuscript to a repository, authors shall include an acknowledgment line (see last entry below) and a hyperlink to the fully published version of the article posted on The Journal of Rheumatology website. This helps to ensure the article is correctly cited and will guarantee that the fully published and definitive version is readily available to those accessing the article from public repositories. The Journal authorizes deposit, in institutional and/or centrally organized repositories, of the accepted manuscript as prepared by the authors before publisher copy-editing and proof correction. For clarity the final published version of the article as it appears in The Journal of Rheumatology after copyediting and proof correction may not be deposited. Authors should include the following credit line when depositing their accepted manuscripts. "This is a pre-copy-editing, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL for the fully published article here]." Full Release Publication Option. For those authors of original research articles whose funding agency requires public access to the funded research, The Journal of Rheumatology offers the option of Full Release publication. With this option, the author can elect to pay a fee to make the article available to non-subscribers from the time of first publication on The Journal of Rheumatology website. In contrast, articles published in the usual way, i.e., not as Full Release content, are subject to the usual subscription access controls. Full Release articles will be identified on our online table of contents. An article published under the Full Release option is subject to a publication charge of $3500. Regarding deposit requirement, such funded authors may also self-deposit the final peer reviewed version of the manuscript to a centrally organized repository, such as PubMedCentral. Contact Information. The Journal of Rheumatology, 365 Bloor Street East, Suite 901, Toronto, ON M4W 3L4, Canada. Tel: 416 967 5155; FAX: 416 967 7556; E-mail: jrheum@jrheum.com; Website: http//:www.jrheum.com All rights reserved. |